ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GLMD Galmed Pharmaceuticals Ltd

0.3874
0.0023 (0.60%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Galmed Pharmaceuticals Ltd NASDAQ:GLMD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0023 0.60% 0.3874 0.35 0.9777 0.398999 0.3666 0.3963 22,429 05:00:04

Crypto, Cannabis and Biotech Companies to Watch, Comprehensive Coverage

18/06/2018 1:05pm

InvestorsHub NewsWire


New York, NY -- June 18, 2018 -- InvestorsHub NewsWire -- Traders News Source brings you current reports on the hottest market sectors and stocks. Read the full comprehensive reports with analyst’s reviews, financial data, recent events and more.

Singlepoint, Inc. (OTCQB: SING) recently announced the company has completed production of their crypto wallet application commercial featuring original Shark Tank member Kevin Harrington. The next step for the company will be to receive approvals from the major national networks.
Research Report, copy and paste to browser may be required – https://tradersnewssource.com/singlepoint/

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), just announced top-line, 52-week results from the global Phase 2b ARREST study. In the ARREST study, patients underwent MRS and biopsy at baseline and week 52, which were centrally read, blinded to treatment allocation. The primary endpoint of the study was the change from baseline to end of study in liver triglycerides ratio as measured by MRS (Aramchol 600mg vs. placebo).
Research Report, copy and paste to browser may be required – https://tradersnewssource.com/galmed-pharmaceuticals/

Emblem Corp. (OTCPK: EMMBF) is a licensed producer of medical cannabis under the Canadian Access to Cannabis for Medical Purposes Regulations. On May 29th, the company reported financial and operating results for the first quarter ended March 31, 2018. Along with record sales and registered patient counts, EMMBF’s first quarter progressed rapidly in all areas (including market, operations and financial flexibility).
Research Report, copy and paste to browser may be required – https://tradersnewssource.com/emblem-corp/

The Supreme Cannabis Company, Inc. (OTCPK: SPRWF) is a Canadian publicly traded company, engaged into cultivation and distribution of sun-grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000-sq. Ft. Hybrid Greenhouse facility.
Research Report, copy and paste to browser may be required – https://tradersnewssource.com/supreme-cannabis/
 
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source

 

1 Year Galmed Pharmaceuticals Chart

1 Year Galmed Pharmaceuticals Chart

1 Month Galmed Pharmaceuticals Chart

1 Month Galmed Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock